ID   RFOX3_HUMAN             Reviewed;         312 AA.
AC   A6NFN3; B4DEG6; B4DF29;
DT   02-SEP-2008, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 4.
DT   18-JUN-2025, entry version 126.
DE   RecName: Full=RNA binding protein fox-1 homolog 3;
DE   AltName: Full=Fox-1 homolog C;
DE   AltName: Full=Neuronal nuclei antigen;
DE            Short=NeuN antigen;
GN   Name=RBFOX3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   SUBCELLULAR LOCATION.
RX   PubMed=24215932; DOI=10.1016/j.neulet.2013.10.037;
RA   Lucas C.H., Calvez M., Babu R., Brown A.;
RT   "Altered subcellular localization of the NeuN/Rbfox3 RNA splicing factor in
RT   HIV-associated neurocognitive disorders (HAND).";
RL   Neurosci. Lett. 558:97-102(2014).
CC   -!- FUNCTION: Pre-mRNA alternative splicing regulator. Regulates
CC       alternative splicing of RBFOX2 to enhance the production of mRNA
CC       species that are targeted for nonsense-mediated decay (NMD).
CC       {ECO:0000250|UniProtKB:Q8BIF2}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24215932}. Cytoplasm
CC       {ECO:0000269|PubMed:24215932}. Note=Largely restricted to neuronal
CC       nuclei. However, significant cytoplasmic localization in neurons from
CC       brains from HIV-infected individuals with cognitive impairment.
CC       {ECO:0000269|PubMed:24215932}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=A6NFN3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A6NFN3-2; Sequence=VSP_056241;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK293617; BAG57077.1; -; mRNA.
DR   EMBL; AK293905; BAG57290.1; -; mRNA.
DR   EMBL; AC020689; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC021534; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC027824; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC055858; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073624; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC142247; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS45805.1; -. [A6NFN3-1]
DR   RefSeq; NP_001076044.1; NM_001082575.3. [A6NFN3-1]
DR   RefSeq; NP_001337382.1; NM_001350453.2. [A6NFN3-1]
DR   RefSeq; NP_001372757.1; NM_001385828.1. [A6NFN3-1]
DR   RefSeq; NP_001372758.1; NM_001385829.1. [A6NFN3-1]
DR   RefSeq; NP_001372759.1; NM_001385830.1. [A6NFN3-1]
DR   RefSeq; NP_001372760.1; NM_001385831.1. [A6NFN3-1]
DR   RefSeq; NP_001372761.1; NM_001385832.1. [A6NFN3-1]
DR   RefSeq; NP_001372762.1; NM_001385833.1. [A6NFN3-1]
DR   RefSeq; NP_001372763.1; NM_001385834.1. [A6NFN3-1]
DR   RefSeq; NP_001372764.1; NM_001385835.1. [A6NFN3-1]
DR   RefSeq; NP_001372765.1; NM_001385836.1. [A6NFN3-1]
DR   RefSeq; NP_001372766.1; NM_001385837.1. [A6NFN3-1]
DR   RefSeq; NP_001372767.1; NM_001385838.1. [A6NFN3-1]
DR   RefSeq; NP_001372768.1; NM_001385839.1. [A6NFN3-1]
DR   RefSeq; NP_001372769.1; NM_001385840.1. [A6NFN3-1]
DR   RefSeq; NP_001372770.1; NM_001385841.1. [A6NFN3-1]
DR   RefSeq; NP_001372771.1; NM_001385842.1. [A6NFN3-1]
DR   RefSeq; XP_016879699.1; XM_017024210.1.
DR   AlphaFoldDB; A6NFN3; -.
DR   SMR; A6NFN3; -.
DR   BioGRID; 127004; 47.
DR   FunCoup; A6NFN3; 1512.
DR   IntAct; A6NFN3; 17.
DR   STRING; 9606.ENSP00000463653; -.
DR   GlyGen; A6NFN3; 1 site.
DR   iPTMnet; A6NFN3; -.
DR   PhosphoSitePlus; A6NFN3; -.
DR   BioMuta; RBFOX3; -.
DR   jPOST; A6NFN3; -.
DR   MassIVE; A6NFN3; -.
DR   PaxDb; 9606-ENSP00000463653; -.
DR   PeptideAtlas; A6NFN3; -.
DR   ProteomicsDB; 1060; -. [A6NFN3-1]
DR   Pumba; A6NFN3; -.
DR   Antibodypedia; 32645; 517 antibodies from 37 providers.
DR   DNASU; 146713; -.
DR   Ensembl; ENST00000580155.5; ENSP00000463653.1; ENSG00000167281.20. [A6NFN3-1]
DR   Ensembl; ENST00000584778.5; ENSP00000462007.1; ENSG00000167281.20. [A6NFN3-2]
DR   GeneID; 146713; -.
DR   KEGG; hsa:146713; -.
DR   UCSC; uc010dhs.5; human. [A6NFN3-1]
DR   AGR; HGNC:27097; -.
DR   CTD; 146713; -.
DR   DisGeNET; 146713; -.
DR   GeneCards; RBFOX3; -.
DR   HGNC; HGNC:27097; RBFOX3.
DR   HPA; ENSG00000167281; Tissue enhanced (brain, intestine, urinary bladder).
DR   MalaCards; RBFOX3; -.
DR   MIM; 616999; gene.
DR   neXtProt; NX_A6NFN3; -.
DR   OpenTargets; ENSG00000167281; -.
DR   VEuPathDB; HostDB:ENSG00000167281; -.
DR   eggNOG; KOG0125; Eukaryota.
DR   GeneTree; ENSGT00940000159924; -.
DR   HOGENOM; CLU_048440_0_0_1; -.
DR   InParanoid; A6NFN3; -.
DR   OrthoDB; 5382468at2759; -.
DR   PAN-GO; A6NFN3; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; A6NFN3; -.
DR   TreeFam; TF315942; -.
DR   PathwayCommons; A6NFN3; -.
DR   Reactome; R-HSA-9768919; NPAS4 regulates expression of target genes.
DR   SignaLink; A6NFN3; -.
DR   SIGNOR; A6NFN3; -.
DR   BioGRID-ORCS; 146713; 22 hits in 1146 CRISPR screens.
DR   CD-CODE; DEE660B4; Stress granule.
DR   ChiTaRS; RBFOX3; human.
DR   GenomeRNAi; 146713; -.
DR   Pharos; A6NFN3; Tbio.
DR   PRO; PR:A6NFN3; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; A6NFN3; protein.
DR   Bgee; ENSG00000167281; Expressed in right hemisphere of cerebellum and 117 other cell types or tissues.
DR   ExpressionAtlas; A6NFN3; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0007399; P:nervous system development; IBA:GO_Central.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   CDD; cd12407; RRM_FOX1_like; 1.
DR   FunFam; 3.30.70.330:FF:000004; RNA binding fox-1 homolog 1; 1.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR025670; Fox-1_C_dom.
DR   InterPro; IPR034237; FOX1_RRM.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR017325; RBFOX1-3.
DR   InterPro; IPR047131; RBFOX1-like.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR15597; ATAXIN 2-BINDING PROTEIN 1-RELATED; 1.
DR   PANTHER; PTHR15597:SF25; RNA BINDING PROTEIN FOX-1 HOMOLOG 3; 1.
DR   Pfam; PF12414; Fox-1_C; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   PIRSF; PIRSF037932; Ataxin_2_bd_A2BP; 1.
DR   SMART; SM00360; RRM; 1.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 1.
DR   PROSITE; PS50102; RRM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Methylation; mRNA processing;
KW   mRNA splicing; Nucleus; Proteomics identification; Reference proteome;
KW   RNA-binding.
FT   CHAIN           1..312
FT                   /note="RNA binding protein fox-1 homolog 3"
FT                   /id="PRO_0000349207"
FT   DOMAIN          100..175
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          1..104
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..29
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        49..87
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            100
FT                   /note="Interaction with RNA"
FT                   /evidence="ECO:0000250"
FT   SITE            108
FT                   /note="Interaction with RNA"
FT                   /evidence="ECO:0000250"
FT   SITE            109
FT                   /note="Interaction with RNA"
FT                   /evidence="ECO:0000250"
FT   SITE            133
FT                   /note="Interaction with RNA"
FT                   /evidence="ECO:0000250"
FT   SITE            138
FT                   /note="Interaction with RNA"
FT                   /evidence="ECO:0000250"
FT   SITE            142
FT                   /note="Interaction with RNA"
FT                   /evidence="ECO:0000250"
FT   SITE            166
FT                   /note="Interaction with RNA"
FT                   /evidence="ECO:0000250"
FT   SITE            176
FT                   /note="Interaction with RNA"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         223
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIF2"
FT   MOD_RES         223
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIF2"
FT   MOD_RES         272
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIF2"
FT   VAR_SEQ         312
FT                   /note="M -> MVRSPGPPSPGCQS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056241"
SQ   SEQUENCE   312 AA;  33873 MW;  62D564F8A7862862 CRC64;
     MAQPYPPAQY PPPPQNGIPA EYAPPPPHPT QDYSGQTPVP TEHGMTLYTP AQTHPEQPGS
     EASTQPIAGT QTVPQTDEAA QTDSQPLHPS DPTEKQQPKR LHVSNIPFRF RDPDLRQMFG
     QFGKILDVEI IFNERGSKGF GFVTFETSSD ADRAREKLNG TIVEGRKIEV NNATARVMTN
     KKTGNPYTNG WKLNPVVGAV YGPEFYAVTG FPYPTTGTAV AYRGAHLRGR GRAVYNTFRA
     APPPPPIPTY GAVVYQDGFY GAEIYGGYAA YRYAQPAAAA AAYSDSYGRV YAAADPYHHT
     IGPAATYSIG TM
//
